JP Morgan 2025: Radiopharmaceuticals M&A fuels Telix’s busy year
Following a year thick with acquisitions across the radiopharmaceutical supply chain, Telix Pharmaceuticals has announced a 55% year-on-year revenue increase…
All articles by Frankie Fattorini
Frankie Fattorini
Frankie Fattorini is a healthcare and pharmaceutical reporter. His background is in genomics research, and he has also worked in medical communications. Frankie has written freelance articles on emerging technologies and various pieces on oncology and drug development.
-
-
JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year ahead
AstraZeneca says a strong 2024 and stacked pipeline spells potential for further growth in 2025 as the company aims to…
-
JP Morgan 2025: Novartis streamlines its portfolio to drive future growth
Positioning itself as a pure-play innovative medicines company, Novartis is bullish about the growth towards 2030 by placing an emphasis…
-
JP Morgan 2025: Moderna stock suffers after CEO reveals conservative 2025 guidance
Moderna lost more than 20% of its value on the stock market as the company delivered slashed revenue guidance for…
-
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025
Pfizer is cutting costs and refocussing its research and development (R&D) operations in a bid to maintain and grow revenues…
-
Eisbach Bio positions HRD-targeting therapy to supplant PARP inhibitors
Eisbach Bio plans to use a $4.75m grant to advance EIS-12656, a small molecule ALC1 inhibitor to disrupt the genome…
-
How Pfizer management outplayed activist investor Starboard
Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist…
-
New study finds obesity costs US industry $347bn a year
A new study published in Nature Nutrition & Diabetes estimates the economic burden associated with obesity on major US industries…
-
Worldwide 2024 elections pose pivotal shifts in life sciences and healthcare
The outcomes of this year’s US, EU, and UK elections and their downstream effects will lead to drastic changes to…
-
Are dry powder inhalers the key to sustainable respiratory care?
In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder…